Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.43 USD | +0.54% | -0.90% | -8.35% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.35% | 18.05B | |
-4.98% | 182B | |
+2.84% | 112B | |
-2.68% | 68.58B | |
+4.53% | 51.58B | |
+8.00% | 44.24B | |
+9.65% | 43.65B | |
+25.30% | 32.46B | |
-0.17% | 25.61B | |
+21.57% | 25.99B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc., Q3 2022 Earnings Call, Oct 27, 2022